Patents by Inventor Rafal Zielinski

Rafal Zielinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230130134
    Abstract: The present invention relates to methods of treating and preventing viral diseases and infections comprising the administration of hexoses and analogs and their prodrugs thereof that inhibit glycolysis and/or glycosylation.
    Type: Application
    Filed: March 16, 2021
    Publication date: April 27, 2023
    Applicants: Board of Regents, The University of Texas System, Moleculin Biotech, Inc.
    Inventors: Waldemar PRIEBE, Izabela FOKT, Rafal ZIELINSKI, Stanislaw SKORA, Donald PICKER, Walter KLEMP
  • Publication number: 20220347168
    Abstract: Provided is a method of treating cancer cells localized in the lung by administering to such patients a therapeutically effective amount of a liposomal annamycin formulation (L-Ann).
    Type: Application
    Filed: May 12, 2022
    Publication date: November 3, 2022
    Inventors: Waldemar PRIEBE, Rafal ZIELINSKI, Izabela FOKT, Stanislaw SKORA
  • Publication number: 20220175744
    Abstract: Provided herein are methods of treating patients with a combination of a transcription inhibitor (e.g., a STAT3 inhibitor) and an immune checkpoint blockade therapy (e.g., anti-PD-1 therapy, anti-PD-L1 therapy, anti-CTLA-4 therapy). The patient may have a proliferative disease, such as cancer or psoriasis. The patient may have a pathogenic infection.
    Type: Application
    Filed: April 2, 2020
    Publication date: June 9, 2022
    Applicant: Board of Regents, The University of Texas System
    Inventors: Waldemar PRIEBE, Rafal ZIELINSKI, Michael CURRAN, Midan AI
  • Patent number: 10703721
    Abstract: In one aspect, the present disclosure provides caffeic acid derivatives of the formula: wherein the variables are as defined herein. In another aspect, the present disclosure provides pharmaceutical compositions and methods of using of the compounds disclosed herein, including for the treatment of cancer.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: July 7, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Waldemar Priebe, Stanislaw Skora, Izabela Fokt, Rafal Zielinski, Arumugam Jayakumar, Radjendirane Venugopal
  • Publication number: 20190177276
    Abstract: In one aspect, the present disclosure provides caffeic acid derivatives of the formula: wherein the variables are as defined herein. In another aspect, the present disclosure provides pharmaceutical compositions and methods of using of the compounds disclosed herein, including for the treatment of cancer.
    Type: Application
    Filed: November 9, 2018
    Publication date: June 13, 2019
    Inventors: Waldemar PRIEBE, Stanislaw SKORA, Izabela FOKT, Rafal ZIELINSKI, Arumugam JAYAKUMAR, Radjendirane VENUGOPAL
  • Patent number: 10168985
    Abstract: Techniques related to dynamic audio codec enumeration and dynamically providing communication between drivers are discussed. Such techniques may include providing back door communication between the drivers via mailbox registers in audio codec hardware.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: January 1, 2019
    Assignee: Intel Corporation
    Inventors: Abid A. Mullah, Rafal Zielinski, Naveen S. G., Ganesh Ram S. T.
  • Publication number: 20170177294
    Abstract: Techniques related to dynamic audio codec enumeration and dynamically providing communication between drivers are discussed. Such techniques may include providing back door communication between the drivers via mailbox registers in audio codec hardware.
    Type: Application
    Filed: December 21, 2015
    Publication date: June 22, 2017
    Inventors: Abid A. Mullah, Rafal Zielinski, Naveen S.G., Ganesh Ram S.T.